Limitation of the Ventilatory Response to Exercise in the Master Athlete (LAHMESS)

Centre Hospitalier Universitaire de Nice

Status: Terminated

Conditions: Healthy Volunteers

Treatments: Other: Heliox; Other: Air

Study type: Interventional

Funder types: Other

Identifiers

NCT05307276

21-PP-10

Details and patient eligibility

About

It is generally accepted that the ventilatory system is not a limiting factor in physical exercise in terms of performance or exercise tolerance in healthy subjects. The ventilatory system would be oversized in relation to the stresses it has to cope with, even during maximum intensity exercise. However, some highly trained endurance athletes may be exceptions to this rule. A limitation of the expiratory flow is indeed sometimes found in these athletes, whose maximum values of ventilation can confront the mechanical limits of their ventilatory system. This phenomenon could be accentuated in elderly athletes (known as "master athletes") under the effect of structural and functional pulmonary alterations that accompany aging. Our hypothesis : What is the prevalence of exercise expiratory flow limitation in the master athlete and does it cause a decrease in physical performance via an acceleration of locomotor muscle fatigue?

Enrollment: 3 patients

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Non-smoker (active or passive) or ex-smoker of less than 5 pack-years and stopped for more than 10 years.
• No known significant chronic pathology.
• No symptoms suggesting a progressive pathology.
• No contraindication to physical exercise. Normal Pulmonary Functional Test (PFT).
• Participants affiliated to the social security system

Exclusion criteria

• Vulnerable persons as defined in Articles L. 1121-5 to L.1121-8 and L.1122-1-2 of the Public Health Code (e.g. persons deprived of liberty, minors, adults protected, etc.),
• Participants with a medical contraindication to sports practice,
• Cardiovascular, respiratory, neuromuscular and/or significant metabolic,
• Participants with declared pathology or medical treatment,
• Smoking or drug use,
• Significant chronic drug treatment,
• Lack of consent.
• Refusal to cooperate
• Recent rhino-bronchial infection (within last 4 weeks)
• Mental disability

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

3 participants in 1 patient group

Healthy volunteers

Other group

Description:

Following the selection visit (#V0) to verify the inclusion and non-inclusion criteria, participants will make 2 visits (#V1 and #V2) including in particular a Respiratory Functional Exploration (EFR) and a triangular

Treatment:

Other: Air

Other: Heliox